Lv41
510 积分 2023-02-15 加入
Management of locally advanced non‐small cell lung cancer: state of the art and future directions
1小时前
待确认
Nivolumab versus docetaxel in a predominantly Chinese patient population with previously treated advanced non-small cell lung cancer: 2-year follow-up from a randomized, open-label, phase 3 study (CheckMate 078)
1个月前
已完结
Nivolumab versus docetaxel in a predominantly Chinese patient population with previously treated advanced non-small cell lung cancer: 2-year follow-up from a randomized, open-label, phase 3 study (CheckMate 078)
1个月前
已关闭
Checkpoint inhibitors as dual immunotherapy in advanced non-small cell lung cancer: a meta-analysis
2个月前
已完结
原发性肺癌罕见靶点靶向治疗中国临床诊疗指南（2024版）
2个月前
已完结
Neoadjuvant and Adjuvant Treatment for Early-Stage Resectable Non-small Cell Lung Cancer (NSCLC): Consensus Recommendations from the International Association for the Study of Lung Cancer (IASLC)
2个月前
已完结
Protocols for Studies of Intraocular Lens Formula Accuracy
3个月前
已完结
Bronchial Artery Chemoembolization for Hemoptysis in Advanced Primary Lung Cancer
3个月前
已完结
Image-Guided Percutaneous and Transarterial Therapies for Primary and Metastatic Lung Cancer
3个月前
已关闭
Efficacy and Safety of Super-Selective Bronchial Arterial Infusion Chemotherapy in the Treatment of Advanced Non-Small Cell Lung Cancer
3个月前
已完结
皖公网安备34019202002308
